Signify Health, Inc. (SGFY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Signify Health, Inc. (SGFY) trades at $30.49. Signify Health, Inc. operates a healthcare platform leveraging analytics, technology, and provider networks to improve healthcare delivery. Market cap: $8.93B, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for SGFY: SGFY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SGFY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SGFY: 1/1 perspectives are bearish.
How is this calculated? →Signify Health, Inc. (SGFY) Healthcare & Pipeline Overview
Signify Health, Inc. delivers healthcare solutions through its technology-enabled platform, focusing on home-based health evaluations and episode-of-care management. The company partners with health plans and providers to enhance care delivery and outcomes, leveraging data analytics and provider networks within the evolving healthcare landscape.
What Is the Investment Thesis for SGFY?
Signify Health operates in a growing market for value-based care and home health services. The company's focus on analytics and technology to improve healthcare delivery positions it to capitalize on the shift towards more efficient and outcome-driven healthcare models. With a market capitalization of $8.93B, Signify Health's future growth depends on its ability to expand its network, manage costs effectively, and demonstrate improved patient outcomes. The negative P/E ratio of -41.22 and a negative profit margin of -16.2% indicate potential profitability challenges. Key catalysts include expanding partnerships with health plans and successful execution of bundled payment programs. The company's beta of 0.36 suggests lower volatility compared to the overall market.
Based on FMP financials and quantitative analysis
SGFY Key Highlights
- Market Cap of $8.93B reflects investor valuation of Signify Health's potential in the healthcare technology sector.
- Gross Margin of 45.3% indicates a strong ability to generate revenue from services offered.
- Operating through two segments: Home & Community Services and Episodes of Care Services, allows for diversified revenue streams.
- Partnership with Centers for Medicare and Medicaid Services (CMS) under the Bundled Payment for Care Improvement Advanced program.
- Serves a diverse range of clients, including health plans, government entities, employers, health systems, and physician groups.
Who Are SGFY's Competitors?
SGFY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BPMC Blueprint Medicines Corporation | $129.46 | +0.14% | $8.36B | 46 |
| CERE Cerevel Therapeutics Holdings, Inc. | $44.96 | +0.74% | $8.19B | 46 |
| IMGN ImmunoGen | $31.23 | +0.02% | $8.73B | 46 |
| LHCG LHC Group, Inc. | $169.81 | +0.00% | $5.29B | 45 |
| OSH Oak Street Health, Inc. | $39.00 | +0.08% | $9.52B | 55 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SGFY's Key Strengths?
- Technology-enabled platform for healthcare delivery.
- Strong network of healthcare providers and partnerships.
- Expertise in managing episodic payment programs.
- Data analytics capabilities for personalized care.
What Are SGFY's Weaknesses?
- Negative P/E ratio and profit margin indicate potential profitability challenges.
- Dependence on government programs and regulations.
- Competition from other healthcare providers and technology companies.
- Potential for data breaches and privacy concerns.
What Could Drive SGFY Stock Higher?
- Expansion of partnerships with Medicare Advantage plans to increase market reach.
- Continued participation in the Bundled Payment for Care Improvement Advanced program with CMS.
- Launch of new technology-enabled services to improve patient engagement and outcomes.
- Leveraging data analytics to identify and address social determinants of health.
What Are the Key Risks for SGFY?
- Negative return on equity (-14.9%) — the business is not currently generating profit on shareholder capital.
- Insider selling — insiders were net sellers of roughly $5.5M recently.
- Changes in government regulations and healthcare policies could impact revenue and profitability.
- Increased competition from other healthcare providers and technology companies.
- Cybersecurity threats and data breaches could compromise patient data and damage reputation.
- Economic downturn and reduced healthcare spending could affect demand for services.
What Are the Growth Opportunities for SGFY?
- Expansion of Home & Community Services: The market for in-home health evaluations and services is growing, driven by the aging population and the increasing prevalence of chronic diseases. Signify Health can expand its reach by partnering with more Medicare Advantage plans and offering additional services, such as remote patient monitoring and telehealth. This market is estimated to reach $30 billion by 2028, offering significant growth potential.
- Growth in Episodes of Care Services: The shift towards value-based care and bundled payment models creates opportunities for Signify Health to expand its Episodes of Care Services. By partnering with more healthcare providers and demonstrating improved patient outcomes and cost savings, the company can attract more contracts under programs like the Bundled Payment for Care Improvement Advanced program. This segment is projected to grow at a rate of 15% annually over the next five years.
- Leveraging Data Analytics: Signify Health's platform generates a wealth of data that can be used to improve care delivery and outcomes. By investing in advanced analytics and artificial intelligence, the company can identify patterns, predict risks, and personalize care plans. This can lead to better patient outcomes, reduced costs, and increased customer satisfaction. The market for healthcare analytics is expected to reach $68 billion by 2028.
- Strategic Partnerships and Acquisitions: Signify Health can accelerate its growth by forming strategic partnerships with other healthcare companies or acquiring complementary businesses. This can expand its service offerings, geographic reach, and customer base. Potential targets include companies specializing in telehealth, remote patient monitoring, or care management. The company has the financial resources to pursue strategic acquisitions.
- Addressing Social Determinants of Health: There is a growing recognition of the impact of social determinants of health on patient outcomes. Signify Health can expand its services to address these factors, such as food insecurity, housing instability, and transportation barriers. By partnering with community-based organizations and offering targeted interventions, the company can improve the health and well-being of its patients and reduce healthcare costs. This market is estimated to reach $1 trillion by 2030.
What Opportunities Does SGFY Have?
- Expansion of home-based healthcare services.
- Growth in value-based care and bundled payment models.
- Leveraging data analytics to improve patient outcomes.
- Strategic partnerships and acquisitions.
What Threats Does SGFY Face?
- Changes in government regulations and healthcare policies.
- Increased competition from other healthcare providers.
- Economic downturn and reduced healthcare spending.
- Cybersecurity threats and data breaches.
What Are SGFY's Competitive Advantages?
- Proprietary technology platform that integrates analytics, technology, and provider networks.
- Extensive network of healthcare providers and partnerships with health plans.
- Data analytics capabilities that enable personalized care plans and improved outcomes.
- Expertise in managing episodic payment programs and value-based care models.
What Does SGFY Do?
Founded in 2017 and headquartered in Dallas, Texas, Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks across the United States. The company is structured around two primary segments: Home & Community Services and Episodes of Care Services. The Home & Community Services segment provides in-home health evaluations, diagnostic screenings, and services addressing social determinants of health, primarily targeting Medicare Advantage health plans. This segment aims to proactively identify and manage health risks within a patient's home environment. The Episodes of Care Services segment focuses on enhancing healthcare delivery through episodic payment programs, partnering with healthcare providers under the Bundled Payment for Care Improvement Advanced program with the Centers for Medicare and Medicaid Services (CMS). This segment also offers care management services designed to improve patient outcomes and reduce costs. Signify Health serves a diverse range of clients, including health plans, government entities, employers, health systems, and physician groups. The company's operations span multiple locations, including Norwalk, Connecticut; New York, New York; Dallas, Texas; South Dakota; Deerfield, Florida; and Rapid City, reflecting its national presence and commitment to accessible healthcare solutions.
What Products and Services Does SGFY Offer?
- Operates a healthcare platform using analytics, technology, and provider networks.
- Provides in-home health evaluations for Medicare Advantage health plans.
- Offers diagnostic screening and ancillary services.
- Addresses healthcare concerns related to social determinants of health.
- Develops and manages episodic payment programs.
- Partners with healthcare providers under the Bundled Payment for Care Improvement Advanced program.
- Provides care management services to improve patient outcomes.
How Does SGFY Make Money?
- Generates revenue through fees for health evaluations and diagnostic screenings.
- Earns revenue from managing episodic payment programs and care management services.
- Partners with health plans, governments, employers, health systems, and physician groups.
- Leverages technology and data analytics to improve healthcare delivery and reduce costs.
What Industry Does SGFY Operate In?
Signify Health operates within the healthcare information services industry, which is experiencing growth driven by the increasing demand for value-based care and technology-enabled healthcare solutions. The shift towards home-based healthcare and the focus on improving patient outcomes are key trends shaping the industry. The competitive landscape includes companies like BPMC (BioPlus Specialty Pharmacy), CERE (Cerevel Therapeutics Holdings), IMGN (ImmunoGen Inc.), LHCG (LHC Group), and OSH (Oak Street Health), each offering different aspects of healthcare services. Signify Health differentiates itself through its integrated platform that combines analytics, technology, and provider networks to deliver comprehensive care solutions.
Who Are SGFY's Key Customers?
- Health plans, particularly Medicare Advantage plans.
- Government entities, such as the Centers for Medicare and Medicaid Services (CMS).
- Employers seeking to improve the health and well-being of their employees.
- Health systems and physician groups participating in value-based care programs.
ROE -15%Key Financial Metrics
Return on equity for Signify Health, Inc. stands at -14.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.5%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.62 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -2.4%, the inverse of the P/E and a quick read on earnings relative to price.
Signify Health, Inc. (SGFY) Valuation Context
Valued at $8.93B, SGFY is classified as a mid-cap stock.
Company Profile
Signify Health, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Dallas, US. The company is led by CEO Bradford Kyle Armbrester. SGFY has traded publicly since 2021.
F-Score 4/9Financial Health
Signify Health, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.92 places it in the safe zone, indicating low near-term bankruptcy risk.
Net buyingInsider Activity
The most recent 12 insider filings for Signify Health, Inc. break down as 8 sales and 4 purchases. On net that is roughly 3.7M shares acquired (about $5.5M) — insiders putting money in tends to read as conviction.
SGFY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Technology-enabled platform for healthcare delivery.
- Strong network of healthcare providers and partnerships.
- Expertise in managing episodic payment programs.
- Data analytics capabilities for personalized care.
Bear Case
- Negative P/E ratio and profit margin indicate potential profitability challenges.
- Dependence on government programs and regulations.
- Competition from other healthcare providers and technology companies.
- Potential for data breaches and privacy concerns.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SGFY Latest News
No recent news available for SGFY.
SGFY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SGFY.
Price Targets
Wall Street price target analysis for SGFY.
SGFY MoonshotScore
What does this score mean?
The MoonshotScore rates SGFY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Bradford Kyle Armbrester
CEO
Bradford Kyle Armbrester serves as the CEO of Signify Health, Inc. He has extensive experience in the healthcare industry, with a background in healthcare technology and services. Before joining Signify Health, Armbrester held leadership positions at various healthcare companies, where he focused on driving innovation and improving patient outcomes. His expertise includes healthcare analytics, value-based care, and population health management. He is responsible for managing a workforce of 2100 employees.
Track Record: Under Armbrester's leadership, Signify Health has expanded its network of healthcare providers and partnerships with health plans. He has overseen the company's growth in the home-based healthcare market and the development of its technology platform. Key milestones include the successful execution of bundled payment programs and the expansion of the company's data analytics capabilities. He has focused on improving patient outcomes and reducing healthcare costs.
Signify Health, Inc. Healthcare Stock: Key Questions Answered
What does Signify Health, Inc. do?
Signify Health, Inc. operates a technology-enabled healthcare platform that focuses on improving healthcare delivery through home-based services and episode-of-care programs. The company partners with health plans, governments, employers, and healthcare providers to deliver comprehensive care solutions. Its platform utilizes data analytics and provider networks to enhance patient outcomes and reduce healthcare costs. Signify Health's services include in-home health evaluations, diagnostic screenings, and care management for patients with chronic conditions.
What do analysts say about SGFY stock?
Analyst consensus on Signify Health, Inc. (SGFY) stock reflects a neutral outlook, acknowledging the company's growth potential in the healthcare technology sector. Key valuation metrics, such as market capitalization and gross margin, are considered in assessing the company's financial health. Growth considerations include the company's ability to expand its network, manage costs effectively, and demonstrate improved patient outcomes. Analysts monitor the company's performance in the value-based care market and its ability to capitalize on the shift towards home-based healthcare.
What are the main risks for SGFY?
Signify Health, Inc. faces several risks, including changes in government regulations and healthcare policies, which could impact its revenue and profitability. Increased competition from other healthcare providers and technology companies poses a threat to its market share. Cybersecurity threats and data breaches could compromise patient data and damage the company's reputation. An economic downturn and reduced healthcare spending could affect demand for its services. The company's reliance on government programs, such as the Bundled Payment for Care Improvement Advanced program, also presents a risk.
What are the key factors to evaluate for SGFY?
Evaluate SGFY on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does SGFY data refresh on this page?
SGFY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SGFY's recent stock price performance?
Signify Health, Inc. (SGFY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Technology-enabled platform for healthcare delivery. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SGFY overvalued or undervalued right now?
Valuing Signify Health, Inc. (SGFY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SGFY?
Before investing in Signify Health, Inc. (SGFY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- AI analysis is pending and may provide additional insights.